REPLAY HOLDINGS, INC.

ALENIS

scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, or development of pharmaceutical preparations for gene therapy;

ALENIS THERAPEUTICS

THERAPEUTICS;scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, or development of pharmaceutical preparations for gene therapy;

EUDORA

scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, or development of pharmaceutical preparations for gene therapy;

EUDORA THERAPEUTICS

THERAPEUTICS;scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, or development of pharmaceutical preparations for gene therapy;

KALEIBE

scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, or development of pharmaceutical preparations for gene therapy;

KALEIBE THERAPEUTICS

THERAPEUTICS;scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, or development of pharmaceutical preparations for gene therapy;

MATOKO

pharmaceutical products for cell therapy; cell therapy products;: scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; research and development of technology in the field of cell therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapy;

REPLAY

scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, or development of pharmaceutical preparations for gene therapy;

REPLAY HOLDINGS

HOLDINGS;scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, or development of pharmaceutical preparations for gene therapy;

SYNHLA

pharmaceutical products for cell therapy; cell therapy products;scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; research and development of technology in the field of cell therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapy;

SYNHSV

pharmaceutical products for gene therapy; gene therapy products;scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of DNA delivery technology for purposes of providing gene therapy; testing, inspection, research, and development of pharmaceutical preparations for gene therapy;

UCELL

pharmaceutical products for cell therapy; cell therapy products;U CELL; YOU CELL;scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; research and development of technology in the field of cell therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapy;